Jane Street
CLBT icon

Jane Street’s Cellebrite CLBT Stock Holding History

Jane Street’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-45,700
Closed -$824K – 11734
2025
Q4 		$824K Buy
45,700
+34,100
+294% +$612K ﹤0.01% 6554
2025
Q3 		$215K Buy
+11,600
New +$182K ﹤0.01% 9540

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
VC
Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
NTCM
Nine Ten Capital Management Chicago, Illinois $315M AUM 62.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Jane Street's CLBT Position: Q1 2026 in Review

Jane Street increased its Cellebrite (CLBT) stake by 198% in Q1 2026, buying an estimated $7.16M and bringing the position to 714,514 shares worth $9.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2562.

Jane Street first reported a position in CLBT in Q1 2024 and has held it in 7 quarters since. 220 funds tracked by Wall St. Rank hold CLBT as of Q1 2026.

  • Jane Street held 714,514 shares of Cellebrite worth $9.85M as of Q1 2026.
  • Jane Street bought 474,991 Cellebrite shares in Q1 2026, an estimated $7.16M.
  • Cellebrite made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #2562 holding.
  • Jane Street first reported a position in Cellebrite in Q1 2024 and has held it in 7 quarters since.
  • 220 funds tracked by Wall St. Rank held Cellebrite as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.